Ipsen S.A.
OTC: IPSEY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- David Loew
- Employees
- 5,358
- Headquarters
- Boulogne-Billancourt, France
- IPO year
- 2012
- Market cap
- $58.0B
- Website
- https://www.ipsen.com
Loading IPSEY…
Loading profile data…Frequently asked questions about IPSEY
What does Ipsen S.A. (IPSEY) do?
Ipsen S.A. operates as a global biopharmaceutical company, specializing in the research, development, and marketing of innovative medicines. Its therapeutic focus areas encompass oncology, neuroscience, gastroenterology, cognitive disorders, and various rare diseases. The company's diverse product portfolio includes significant oncology treatmen...
Where does IPSEY trade?
Ipsen S.A. (IPSEY) trades on the Other OTC.
What sector is IPSEY in?
Ipsen S.A. (IPSEY) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Ipsen S.A.?
David Loew is the chief executive officer of Ipsen S.A. (IPSEY).
Where is Ipsen S.A. headquartered?
Ipsen S.A. is headquartered in France.
Does IPSEY pay a dividend?
Yes — Ipsen S.A. (IPSEY) paid a trailing twelve-month dividend of USD 0.46 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did IPSEY go public?
Ipsen S.A. (IPSEY) completed its initial public offering in 2012.
Is IPSEY an ADR?
Yes — IPSEY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Ipsen S.A. reporting and dividends follow the underlying issuer.